Intuitive Surgical returns 16.77% annually over 10 years

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Intuitive Surgical delivered an average annual return of 16.77% over the last ten years, surpassing the market by 3.61% annually. With a current market capitalization of $123.22 billion, a $100 investment made a decade ago has grown to $471.67.

powered bylight_fuzz_icon
46200028

*this image is generated using AI for illustrative purposes only.

Intuitive Surgical has generated an average annual return of 16.77% over the past decade, outperforming the market by 3.61% on an annualized basis. The company currently commands a market capitalization of $123.22 billion. This performance highlights the impact of compounded returns on long-term equity growth.

Investment Growth Analysis

If an investor had purchased $100 worth of Intuitive Surgical stock ten years ago, that investment would be valued at $471.67 today. This calculation is based on the current trading price of $347.92 per share.

Key Financial Metrics

Metric Value
Average Annual Return 16.77%
Market Outperformance 3.61%
Current Market Capitalization $123.22 billion
Current Share Price $347.92
10-Year Growth on $100 $471.67

The primary insight from this data is the significant effect that compounded returns can have on capital appreciation over extended periods.

Can Intuitive Surgical maintain its 16.77% annualized return over the next decade given current market saturation?

How might increasing competition in the robotic surgery space impact the company's future market capitalization?

What are the potential risks to Intuitive Surgical's growth trajectory from regulatory changes or healthcare cost pressures?

like17
dislike

Raymond James maintains Outperform on Intuitive Surgical, cuts target to $483

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Raymond James analyst Jayson Bedford maintained an Outperform rating on Intuitive Surgical (NASDAQ: ISRG) while lowering the price target to $483 from $577, reflecting a revised valuation outlook.

powered bylight_fuzz_icon
45163168

*this image is generated using AI for illustrative purposes only.

Raymond James analyst Jayson Bedford has maintained an Outperform rating on Intuitive Surgical (NASDAQ: ISRG) while lowering the price target to $483. The reduction from the previous target of $577 reflects a revised valuation outlook for the stock. The Outperform stance suggests the stock is expected to outperform the broader market.

Rating and Price Target Details

The updated assessment provides a new benchmark for investors tracking the medical device company. The adjustment in the price target indicates a shift in the firm's expectations regarding the company's near-term performance.

Metric Value
Rating Outperform
Price Target $483
Previous Target $577

What specific factors drove the significant reduction in the valuation outlook?

How might this price target adjustment influence investor sentiment in the near term?

What are the potential risks or opportunities for Intuitive Surgical in the current market?

like20
dislike

More News on Intuitive Surgical Inc